[Targets and studies on anti-SARS drugs]
- PMID: 15171664
[Targets and studies on anti-SARS drugs]
Similar articles
-
Severe acute respiratory syndrome treatment: present status and future strategy.Curr Opin Investig Drugs. 2003 Aug;4(8):918-20. Curr Opin Investig Drugs. 2003. PMID: 14508874 Review. No abstract available.
-
Immunomodulatory activities of the herbal formula Kwan Du Bu Fei Dang in healthy subjects: a randomised, double-blind, placebo-controlled study.Hong Kong Med J. 2011 Feb;17 Suppl 2:41-3. Hong Kong Med J. 2011. PMID: 21368336 Clinical Trial. No abstract available.
-
Severe acute respiratory syndrome: scientific and anecdotal evidence for drug treatment.Curr Opin Investig Drugs. 2004 Feb;5(2):179-85. Curr Opin Investig Drugs. 2004. PMID: 15043392 Review.
-
[Three-dimensional structure prediction of the viral protein in the development of anti SARS drugs].Tanpakushitsu Kakusan Koso. 2007 Aug;52(10 Suppl):1082-7. Tanpakushitsu Kakusan Koso. 2007. PMID: 17824221 Japanese. No abstract available.
-
Potential targets for anti-SARS drugs in the structural proteins from SARS related coronavirus.Peptides. 2004 Jun;25(6):901-8. doi: 10.1016/j.peptides.2004.03.002. Peptides. 2004. PMID: 15203235 Free PMC article.
Cited by
-
Attenuation of acute lung injury in mice by oxymatrine is associated with inhibition of phosphorylated p38 mitogen-activated protein kinase.J Ethnopharmacol. 2005 Apr 8;98(1-2):177-83. doi: 10.1016/j.jep.2005.01.026. J Ethnopharmacol. 2005. PMID: 15763380 Free PMC article.
-
Deciphering the biosynthetic codes for the potent anti-SARS-CoV cyclodepsipeptide valinomycin in Streptomyces tsusimaensis ATCC 15141.Chembiochem. 2006 Mar;7(3):471-7. doi: 10.1002/cbic.200500425. Chembiochem. 2006. PMID: 16511823 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous